BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Zidan AA, Mosalam EM. Enhanced anticancer effect and reduced toxicity of doxorubicin in combination with thymoquinone released from poly-N-acetyl glucosamine nanomatrix in mice bearing solid Ehrlish carcinoma. Eur J Pharm Sci. 2017;109:525-532. [PMID: 28890201 DOI: 10.1016/j.ejps.2017.09.012] [Cited by in Crossref: 22] [Cited by in F6Publishing: 22] [Article Influence: 4.4] [Reference Citation Analysis]
Number Citing Articles
1 Homayoonfal M, Asemi Z, Yousefi B. Potential anticancer properties and mechanisms of thymoquinone in osteosarcoma and bone metastasis. Cell Mol Biol Lett 2022;27:21. [PMID: 35236304 DOI: 10.1186/s11658-022-00320-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
2 Mehraj T, Elkanayati RM, Farooq I, Mir TM. A review of Nigella sativa and its active principles as anticancer agents. Black Seeds (Nigella Sativa) 2022. [DOI: 10.1016/b978-0-12-824462-3.00012-3] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
3 Prasher P, Sharma M. Biomedical Applications of Green Nanomaterials. Handbook of Green and Sustainable Nanotechnology 2022. [DOI: 10.1007/978-3-030-69023-6_28-1] [Reference Citation Analysis]
4 Su X, Zhang X, Liu W, Yang X, An N, Yang F, Sun J, Xing Y, Shang H. Advances in the application of nanotechnology in reducing cardiotoxicity induced by cancer chemotherapy. Semin Cancer Biol 2021:S1044-579X(21)00215-7. [PMID: 34375726 DOI: 10.1016/j.semcancer.2021.08.003] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
5 Al-Gabri NA, Saghir SAM, Al-Hashedi SA, El-Far AH, Khafaga AF, Swelum AA, Al-Wajeeh AS, Mousa SA, Abd El-Hack ME, Naiel MAE, El-Tarabily KA. Therapeutic Potential of Thymoquinone and Its Nanoformulations in Pulmonary Injury: A Comprehensive Review. Int J Nanomedicine 2021;16:5117-31. [PMID: 34349511 DOI: 10.2147/IJN.S314321] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Fatfat Z, Fatfat M, Gali-Muhtasib H. Therapeutic potential of thymoquinone in combination therapy against cancer and cancer stem cells. World J Clin Oncol 2021; 12(7): 522-543 [PMID: 34367926 DOI: 10.5306/wjco.v12.i7.522] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
7 El-Far AH, Salaheldin TA, Godugu K, Darwish NH, Mousa SA. Thymoquinone and its nanoformulation attenuate colorectal and breast cancers and alleviate doxorubicin-induced cardiotoxicity. Nanomedicine (Lond) 2021. [PMID: 34132104 DOI: 10.2217/nnm-2021-0103] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
8 Edris AE. Thymoquinone: Chemistry and Functionality. Black cumin (Nigella sativa) seeds: Chemistry, Technology, Functionality, and Applications 2021. [DOI: 10.1007/978-3-030-48798-0_8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Sonea C, Lupusoru M, Opris I. Augmentation of Nutrition by Nanotechnology. Contemporary Clinical Neuroscience 2021. [DOI: 10.1007/978-3-030-54564-2_19] [Reference Citation Analysis]
10 Abo Mansour HE, El-Batsh MM, Badawy NS, Mehanna ET, Mesbah NM, Abo-Elmatty DM. Ginger Extract Loaded into Chitosan Nanoparticles Enhances Cytotoxicity and Reduces Cardiotoxicity of Doxorubicin in Hepatocellular Carcinoma in Mice. Nutr Cancer 2020;:1-16. [PMID: 32972241 DOI: 10.1080/01635581.2020.1823436] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
11 Shende P, Mallick C. Nanonutraceuticals: A way towards modern therapeutics in healthcare. Journal of Drug Delivery Science and Technology 2020;58:101838. [DOI: 10.1016/j.jddst.2020.101838] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
12 Bashir AO, El-mesery ME, Anwer R, Eissa LA. Thymoquinone potentiates miR-16 and miR-375 expressions in hepatocellular carcinoma. Life Sciences 2020;254:117794. [DOI: 10.1016/j.lfs.2020.117794] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 9.5] [Reference Citation Analysis]
13 Elsherbiny NM, El-Sherbiny M, Zaitone SA. Diallyl trisulfide potentiates chemotherapeutic efficacy of doxorubicin in experimentally induced mammary carcinoma: Role of Notch signaling. Pathol Res Pract 2020;216:153139. [PMID: 32853959 DOI: 10.1016/j.prp.2020.153139] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
14 El-Far AH, Tantawy MA, Al Jaouni SK, Mousa SA. Thymoquinone-chemotherapeutic combinations: new regimen to combat cancer and cancer stem cells. Naunyn Schmiedebergs Arch Pharmacol 2020;393:1581-98. [PMID: 32458010 DOI: 10.1007/s00210-020-01898-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 9.0] [Reference Citation Analysis]
15 Rahaiee S, Assadpour E, Faridi Esfanjani A, Silva AS, Jafari SM. Application of nano/microencapsulated phenolic compounds against cancer. Adv Colloid Interface Sci 2020;279:102153. [PMID: 32289738 DOI: 10.1016/j.cis.2020.102153] [Cited by in Crossref: 32] [Cited by in F6Publishing: 33] [Article Influence: 16.0] [Reference Citation Analysis]
16 El-Sisi AE, Sokkar SS, Ibrahim HA, Hamed MF, Abu-Risha SE. Targeting MDR-1 gene expression, BAX/BCL2, caspase-3, and Ki-67 by nanoencapsulated imatinib and hesperidin to enhance anticancer activity and ameliorate cardiotoxicity. Fundam Clin Pharmacol 2020;34:458-75. [PMID: 32080901 DOI: 10.1111/fcp.12549] [Cited by in Crossref: 11] [Cited by in F6Publishing: 12] [Article Influence: 5.5] [Reference Citation Analysis]
17 Mosalam EM, Zidan AA, Mehanna ET, Mesbah NM, Abo-Elmatty DM. Thymoquinone and pentoxifylline enhance the chemotherapeutic effect of cisplatin by targeting Notch signaling pathway in mice. Life Sci 2020;244:117299. [PMID: 31953157 DOI: 10.1016/j.lfs.2020.117299] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 4.0] [Reference Citation Analysis]
18 Fatfat M, Fakhoury I, Habli Z, Mismar R, Gali-Muhtasib H. Thymoquinone enhances the anticancer activity of doxorubicin against adult T-cell leukemia in vitro and in vivo through ROS-dependent mechanisms. Life Sci. 2019;232:116628. [PMID: 31278946 DOI: 10.1016/j.lfs.2019.116628] [Cited by in Crossref: 26] [Cited by in F6Publishing: 27] [Article Influence: 8.7] [Reference Citation Analysis]
19 Lagoa R, Silva J, Rodrigues JR, Bishayee A. Advances in phytochemical delivery systems for improved anticancer activity. Biotechnol Adv 2020;38:107382. [PMID: 30978386 DOI: 10.1016/j.biotechadv.2019.04.004] [Cited by in Crossref: 86] [Cited by in F6Publishing: 74] [Article Influence: 28.7] [Reference Citation Analysis]
20 El-Far AH, Al Jaouni SK, Li W, Mousa SA. Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases. Nutrients 2018;10:E1369. [PMID: 30257423 DOI: 10.3390/nu10101369] [Cited by in Crossref: 41] [Cited by in F6Publishing: 42] [Article Influence: 10.3] [Reference Citation Analysis]
21 Zidan AA, El-Ashmawy NE, Khedr EG, Ebeid EM, Salem ML, Mosalam EM. Loading of doxorubicin and thymoquinone with F2 gel nanofibers improves the antitumor activity and ameliorates doxorubicin-associated nephrotoxicity. Life Sci. 2018;207:461-470. [PMID: 29885348 DOI: 10.1016/j.lfs.2018.06.008] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 3.3] [Reference Citation Analysis]
22 Li L, Ni J, Li M, Chen J, Han L, Zhu Y, Kong D, Mao J, Wang Y, Zhang B, Zhu M, Gao X, Fan G. Ginsenoside Rg3 micelles mitigate doxorubicin-induced cardiotoxicity and enhance its anticancer efficacy. Drug Deliv 2017;24:1617-30. [PMID: 29063791 DOI: 10.1080/10717544.2017.1391893] [Cited by in Crossref: 31] [Cited by in F6Publishing: 28] [Article Influence: 7.8] [Reference Citation Analysis]